Literature DB >> 25359550

Global epidemiology of tuberculosis.

Philippe Glaziou1, Charalambos Sismanidis1, Katherine Floyd1, Mario Raviglione1.   

Abstract

Despite the availability of effective chemotherapy, tuberculosis (TB) killed 1.3 million people in 2012. Alongside HIV, it remains a top cause of death from an infectious disease. Global targets for reductions in the epidemiological burden of TB have been set for 2015 and 2050 within the context of the Millennium Development Goals (MDGs) and by the Stop TB Partnership. Achieving these targets is the focus of national and international efforts in TB control, and showing whether or not they are achieved is of major importance to guide future and sustainable investments. This article provides a short overview of sources of data to estimate TB disease burden; presents estimates of TB incidence, prevalence, and mortality in 2012 and an assessment of progress toward the 2015 targets for reductions in these indicators based on trends since 1990 and projections up to 2015; analyzes trends in TB notifications and in the implementation of the Stop TB Strategy; and considers prospects for elimination of TB after 2015.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25359550      PMCID: PMC4315920          DOI: 10.1101/cshperspect.a017798

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  94 in total

1.  Evolution of WHO policies for tuberculosis control, 1948-2001.

Authors:  M C Raviglione; A Pio
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

2.  Using capture-recapture methods to study recent transmission of tuberculosis.

Authors:  Martien W Borgdorff; Judith R Glynn; Emilia Vynnycky
Journal:  Int J Epidemiol       Date:  2004-05-27       Impact factor: 7.196

3.  14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.

Authors:  Andreas H Diacon; Rodney Dawson; Florian von Groote-Bidlingmaier; Gregory Symons; Amour Venter; Peter R Donald; Christo van Niekerk; Daniel Everitt; Helen Winter; Piet Becker; Carl M Mendel; Melvin K Spigelman
Journal:  Lancet       Date:  2012-07-23       Impact factor: 79.321

4.  Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa.

Authors:  Kate Grimwade; A Willem Sturm; Andrew J Nunn; Daniel Mbatha; Dawn Zungu; Charles F Gilks
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

5.  [Impact on tuberculosis incidence rates of removal of repeat notification records].

Authors:  Ana Luiza Bierrenbach; Antony Peter Stevens; Adriana Bacelar Ferreira Gomes; Elza Ferreira Noronha; Ruth Glatt; Carolina Novaes Carvalho; João Gregório de Oliveira Junior; Maria de Fátima Marinho de Souza
Journal:  Rev Saude Publica       Date:  2007-09       Impact factor: 2.106

Review 6.  Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities.

Authors:  Gavin J Churchyard; Fabio Scano; Alison D Grant; Richard E Chaisson
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

Review 7.  HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Authors:  Charles D Wells; J Peter Cegielski; Lisa J Nelson; Kayla F Laserson; Timothy H Holtz; Alyssa Finlay; Kenneth G Castro; Karin Weyer
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

8.  Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients.

Authors:  Andrea Pantoja; K Floyd; K P Unnikrishnan; R Jitendra; M R Padma; S S Lal; M Uplekar; L S Chauhan; P Kumar; S Sahu; F Wares; K Lönnroth
Journal:  Int J Tuberc Lung Dis       Date:  2009-06       Impact factor: 2.373

9.  Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans.

Authors:  Iñaki Comas; Mireia Coscolla; Tao Luo; Sonia Borrell; Kathryn E Holt; Midori Kato-Maeda; Julian Parkhill; Bijaya Malla; Stefan Berg; Guy Thwaites; Dorothy Yeboah-Manu; Graham Bothamley; Jian Mei; Lanhai Wei; Stephen Bentley; Simon R Harris; Stefan Niemann; Roland Diel; Abraham Aseffa; Qian Gao; Douglas Young; Sebastien Gagneux
Journal:  Nat Genet       Date:  2013-09-01       Impact factor: 38.330

10.  Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study.

Authors:  Graeme Meintjes; Hennie Schoeman; Chelsea Morroni; Douglas Wilson; Gary Maartens
Journal:  BMC Infect Dis       Date:  2008-05-25       Impact factor: 3.090

View more
  58 in total

1.  Social determinants of tuberculosis evaluation among household contacts: a secondary analysis.

Authors:  T Shelby; A J Meyer; E Ochom; P Turimumahoro; D Babirye; A Katamba; J L Davis; M Armstrong-Hough
Journal:  Public Health Action       Date:  2018-09-21

2.  Elevated serum IL-35 and increased expression of IL-35-p35 or -EBI3 in CD4(+)CD25(+) T cells in patients with active tuberculosis.

Authors:  Bin Kong; Gan-Bin Liu; Jun-Ai Zhang; Xiao-Xia Fu; Wen-Yu Xiang; Yu-Chi Gao; Yuan-Bin Lu; Xian-Jing Wu; Feng Qiu; Wan-Dang Wang; Lai-Long Yi; Ji-Xin Zhong; Zheng W Chen; Jun-Fa Xu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 3.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

4.  Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.

Authors:  Kaustuv Nayak; Lichen Jing; Ronnie M Russell; D Huw Davies; Gary Hermanson; Douglas M Molina; Xiaowu Liang; David R Sherman; William W Kwok; Junbao Yang; John Kenneth; Syed F Ahamed; Anmol Chandele; Kaja Murali-Krishna; David M Koelle
Journal:  Tuberculosis (Edinb)       Date:  2015-03-27       Impact factor: 3.131

Review 5.  TB vaccines; promoting rapid and durable protection in the lung.

Authors:  Peter Andersen; Kevin B Urdahl
Journal:  Curr Opin Immunol       Date:  2015-06-22       Impact factor: 7.486

6.  Characterization of Clinical Isolates of Mycobacterium simiae Using Drug Susceptibility Tests and Molecular Analyses.

Authors:  Hoda Dezhkhi; Parissa Farnia; Azam Haddadi; Poopak Farnia; Ali Akbar Velayati
Journal:  Curr Microbiol       Date:  2021-04-13       Impact factor: 2.188

Review 7.  The potential role for infections in the pathogenesis of autoimmune Addison's disease.

Authors:  A Hellesen; E Bratland
Journal:  Clin Exp Immunol       Date:  2018-09-30       Impact factor: 4.330

8.  Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.

Authors:  Rupesh Agrawal; Dinesh Visva Gunasekeran; Robert Grant; Aniruddha Agarwal; Onn Min Kon; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

9.  Altered monocyte phenotypes but not impaired peripheral T cell immunity may explain susceptibility of the elderly to develop tuberculosis.

Authors:  Russell Ault; Varun Dwivedi; Elisha Koivisto; Jenna Nagy; Karin Miller; Kokila Nagendran; Indu Chalana; Xueliang Pan; Shu-Hua Wang; Joanne Turner
Journal:  Exp Gerontol       Date:  2018-07-03       Impact factor: 4.032

10.  Diagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis.

Authors:  Chao Liu; Yun-Liang Cui; Chun-Mei Ding; Yan-Hua Wu; Hui-Li Li; Xiao-Fei Liu; Zhi-De Hu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.